GLP-1 Medications for Weight Loss Now Available!
                    
                    
                 
             
            
                                            
                The city of Birmingham, Alabama, currently has 4 active clinical trials seeking participants for Weight Loss research studies. 
            
                        
                                                                    
    
        
            
                
                                    VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
                                
            
            
         
        
     
    
        
            
                This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults with Type 2 Diabetes who are obese or overweight             
        
        
            
                This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults with Type 2 Diabetes who are obese or overweight 
Read Less
            
         
     
    
        
            
            
            
                Trial Updated:
                08/12/2025
             
         
        
            Locations: Viking Clinical Site #2037, Birmingham, Alabama         
        
                            Viking Clinical Site #2037, Birmingham, Alabama
                     
        
            
        
     
                             
    
        
            
                
                                    VK2735 for Weight Management Phase 3
                                
            
            
         
        
     
    
        
            
                This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults who are obese (BMI ≥30 kg/m2) or overweight (BMI ≥27 kg/m2) with one or more weight related comorbid condition without Type 2 Diabetes.             
        
        
            
                This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults who are obese (BMI ≥30 kg/m2) or overweight (BMI ≥27 kg/m2) with one or more weight related comorbid condition without Type 2 Diabetes. 
Read Less
            
         
     
    
        
            
            
            
                Trial Updated:
                08/12/2025
             
         
        
            Locations: Viking Clinical Site #1037, Birmingham, Alabama         
        
                            Viking Clinical Site #1037, Birmingham, Alabama
                     
        
            
        
     
                             
    
        
            
                
                                    Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance
                                
            
            
         
        
     
    
        
            
                The purpose of this study is to find out what combination of components, if any, offers the best support for keeping weight off after someone loses weight. Long term weight loss maintenance is a challenge for many people who lose weight. There are many strategies, or components, people may use to avoid regain, but investigators do not know if there is a best, or optimal, combination of such components that can be done without adding a lot of cost or other burdens for people.
* The primary goal...  
Read More             
         
        
            
                The purpose of this study is to find out what combination of components, if any, offers the best support for keeping weight off after someone loses weight. Long term weight loss maintenance is a challenge for many people who lose weight. There are many strategies, or components, people may use to avoid regain, but investigators do not know if there is a best, or optimal, combination of such components that can be done without adding a lot of cost or other burdens for people.
* The primary goal of this clinical trial is to identify the optimal package that maximizes weight loss maintenance.
* The study also wants to understand the reasons why these components may work and if certain components help specific sub-groups of people.
Participants will engage in a 16-week Phase 1 Weight Loss Program. Participants who lose 5% or more of their weight during that program will continue to Phase 2 Extended Care and be randomly assigned to 0, 1, 2, 3, or all of four methods of weight loss maintenance. They will use their assigned package for 12 months. Researchers will compare 16 different possible combinations of components and learn which of the 16 packages offers the best support for keeping weight off.
The four components participants could be assigned to in Phase 2 are:
1. Reduced Food Variety: Limiting the variety of foods participants eat by having them choose a few high-calorie, low nutrient foods to eat regularly
2. Home-based Resistance Training: Engaging in exercises that build strength from the comfort of the participant's own home
3. Buddy Training and Support: Having a friend or "buddy" get trained to support the participant
4. Acceptance and Commitment (ACT) Workshops: Having participants learn skills to handle tough thoughts and feelings about weight control in a healthy way
Participants will have their weight measured and complete surveys 4 times if they complete both Phase 1 and Phase 2. During Phase 1, participants will attend weekly group sessions and be in touch with a study staff member investigators call a Wellness Coach. During Phase 2, participants will stay in touch with their Wellness Coach, use their assigned package, and answer questions about their experience periodically. 
Read Less
            
         
     
    
        
            
            
            
                Trial Updated:
                06/02/2025
             
         
        
            Locations: University of Alabama at Birmingham, Birmingham, Alabama         
        
                            University of Alabama at Birmingham, Birmingham, Alabama
                     
        
            Conditions: Obesity Prevention, 
Weight Change, 
Weight Loss, 
Weight Loss Maintenance
         
            
        
     
                             
    
        
            
                
                                    International Weight Control Registry
                                
            
            
         
        
     
    
        
            
                The IWCR is a global scientific study aimed at better understanding the opportunities and barriers for reducing the prevalence of obesity by collecting information from people who have experience with weight management in their everyday lives. The investigators seek to gather information on a wide range of weight management experiences, ranging from weight loss and weight loss maintenance to weight gain and inability to lose weight.             
        
        
            
                The IWCR is a global scientific study aimed at better understanding the opportunities and barriers for reducing the prevalence of obesity by collecting information from people who have experience with weight management in their everyday lives. The investigators seek to gather information on a wide range of weight management experiences, ranging from weight loss and weight loss maintenance to weight gain and inability to lose weight. 
Read Less
            
         
     
    
        
            
            
            
                Trial Updated:
                09/03/2024
             
         
        
            Locations: University of Alabama at Birmingham, Birmingham, Alabama         
        
                            University of Alabama at Birmingham, Birmingham, Alabama